Patheon, a US company that provides contract dosage-form development and manufacturing services to the pharmaceutical and biotechnology industries, has opened new headquarters in Durham, North Carolina and a pharmaceutical development laboratory in nearby Research Triangle Park.

The laboratory will support Patheon’s current US-based pharmaceutical development operations in Cincinatti and will initially offer stability studies, validation testing and analytical chemistry services.

Patheon’s Pharmaceutical Development Services Group covers the spectrum from pre-formulation, formulation and analytical development to clinical manufacturing, scale-up and commercialisation.

“North Carolina is a rapidly growing centre for the pharmaceutical industry, which now boasts 334 biotechnology-related companies,” noted Wes Wheeler, chief executive officer and president of Patheon.